|

LSALT Peptide Clinical Trials

1 actively recruiting trial

Also known as: Metablok

Pipeline

Phase 2: 1

Top Sponsors

  • Arch Biopartners Inc.1

Indications

  • Cardiac Surgery1
  • Heart Disease1
  • Acute Kidney Injury1

Other1 trial

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.